Literature DB >> 14092956

EFFECT OF PROTAMINE SULPHATE ON EXPERIMENTAL TUMOURS IN MICE.

P W MUGGLETON, J G MACLAREN, W J DYKE.   

Abstract

Entities:  

Keywords:  ANTINEOPLASTIC AGENTS; EXPERIMENTAL LAB STUDY; INJECTIONS, SUBCUTANEOUS; MICE; NEOPLASMS, EXPERIMENTAL; PERITONEAL NEOPLASMS; PHARMACOLOGY; PROTAMINES; SARCOMA 180, CROCKER

Mesh：

Substances：

Year:  1964        PMID： 14092956     DOI： 10.1016/s0140-6736(64)92788-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Protamine sulfate-induced enzyme secretion from rabbit neutrophils.

Authors:  J G Elferink; M Deierkauf
Journal:  Inflammation       Date:  1986-12       Impact factor: 4.092

2.  Plasminogen activator of the blood vessels in tumours and in carrageenin-induced granulomas.

Authors:  C R Pick; D B Cater
Journal:  Br J Exp Pathol       Date:  1971-02

3.  Protamine inhibits adenylate cyclase activity: a possible reason for the toxicity of protamine.

Authors:  Z Kiss; R Zamfirova
Journal:  Experientia       Date:  1983-12-15

4.  The action of protamine derivatives and nitrogen mustard on the growth of the Walker 256 rat carcinoma.

Authors:  W H Garvie
Journal:  Br J Cancer       Date:  1965-09       Impact factor: 7.640

5.  Clinical trial of protamine in the treatment of malignant diseases.

Authors:  J E Wright
Journal:  Br J Cancer       Date:  1968-09       Impact factor: 7.640

6.  The effects of protamine on a murine leukemia virus.

Authors:  H A Bates; D S Amatuzio; L Hay; D J Conklin; F B Becker
Journal:  Br J Cancer       Date:  1971-03       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.